Journals / Türk Toraks Dergisi / 2014 / Cilt: 15 - Sayı: 4

Can the use of smokeless tobacco products be Accepted as a harm reduction method in tobacco Addiction?

Pages
136–141
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, we will discuss all aspects of tobacco harm reduction methods.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The goal of smoking cessation treatment is to keep the patient completely away from tobacco and tobacco products.
📊
Key Findings & Data:The aim of harm reduction strategies in tobacco control is to reduce the risks associated with tobacco use.
💡
Conclusion & Impact:In this review, we will discuss all aspects of tobacco harm reduction methods.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The goal of smoking cessation treatment is to keep the patient completely away from tobacco and tobacco products. The aim of harm reduction strategies in tobacco control is to reduce the risks associated with tobacco use. In order to turn it into an opportunity, tobacco companies have developed smokeless tobacco products. Some epidemiological studies have reported that smokeless tobacco products are safer than tobacco smoke. However, this method is not completely harmless. In this review, we will discuss all aspects of tobacco harm reduction methods.

🔖

Cite This Article

ÖZTUNA, F., AYTEMUR, Z. A., ELBEK, O., KILINÇ, O., UYANUSTA, Ç. K., AKÇAY, M. Ş., DAĞLI, E. (2014). Can the use of smokeless tobacco products be Accepted as a harm reduction method in tobacco Addiction?. Türk Toraks Dergisi, Cilt: 15 - Sayı: 4, 136–141. https://ajindex.com/articles/329453

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Rodu B. The scientifc foundation for tobacco harm reduction, 2006-2011. Harm Reduct J 2011
  2. [ CrossRef] 2. Boffetta P, Hecht S, Gray N, et al. Smokeless tobacco and can - cer. Lancet Oncol 2008
  3. [ CrossRef] 3. Lee PN, Hamling J. Systematic review of the relation between smokeless tobacco and cancer in Europe and North America. BMC Medicine 2009
  4. [CrossRef] 4. Lee PN. Circulatory disease and smokeless tobacco in West- ern populations: a review of the evidence. Int J Epidemiol 2007
  5. [CrossRef] 5. Boffetta P, Straif K. Use of smokeless tobacco and risk of myo - cardial infarction and stroke: systematic review with meta-anal - ysis. BMJ 2009
  6. b3060. [CrossRef] 6. England LJ, Levine RJ, Mills JL, et al. Adverse pregnancy outcomes in snuff users. Am J Obstet Gynecol 2003
  7. [ CrossRef] 7. Ramström LM, Foulds J. Role of snus in initiation and cessation of to - bacco smoking in Sweden. Tob Control 2006
  8. [CrossRef] 8. Lund KE, McNeill A, Scheffels J. The use of snus for quitting smoking compared with medicinal products. Nicotine Tob Res 2010
  9. [CrossRef] 9. Rodu B, Godshall WT. Tobacco harm reduction: an alternative cessation strategy for inveterate smokers. Harm Reduction Jour- nal 2006
  10. Rodu B, Cole P. Evidence against a gateway from smokeless tobac - co use to smoking. Nicotine Tob Res 2010
  11. [ CrossRef] 11. Frost-Pineda K, Appleton S, Fisher M, Fox K, Gaworski CL. Does dual use jeopardize the potential role of smokeless tobacco in harm reduction? Nicotine Tob Res 2010
  12. [CrossRef] 12. Euromonitor International. Global briefng- Global tobacco fndings 2011: Battle intensifes. Euromonitor International
  13. Ayo-Yusuf OA, Burns DM. The complexity of ‘harm reduc - tion’ with smokeless tobacco as an approach to tobacco con - trol in low-income and middle-income countries. Tob Control 2012
  14. [CrossRef] 14. Bialous SA, Peeters S. The shameful pastA brief overview of the tobac - co industry in the last 20 years. Tob Control 2012
  15. [CrossRef] 15. Global Tobacco-Key Findings Part Two-Other Tobacco Products Overview and Competitive Environment 2010:27. 16. Gilmore AB. Tobacco epidemic today. Understanding the vector in order to plan effective tobacco control policies: an analy - sis of contemporary tobacco industry materials. Tob Control 2012
  16. [CrossRef] 17. O’Reilly D. Harm reduction. BAT Investor Day, 17-18 May 2011. Hampshire, 2011. 18. Stratto